IS IT A BACTERIAL OR VIRAL INFECTION? USING HOST-RESPONSE TECHNOLOGIES TO DECODE THE IMMUNE SYSTEM AND AID ANTIBIOTIC STEWARDSHIP

Tuesday, September 28, 12 - 12:20 p.m.
Exhibit Hall, Theater 2
Supported by MeMed

OVERVIEW

What would your antibiotic stewardship program look like if you had a 15-minute test that could differentiate between a bacterial and viral infection? MeMed BV® is the first rapid and accurate (blinded and external validation) host-response technology for distinguishing between bacterial and viral infections in under 15 minutes, and it has the potential to change the paradigm in infectious disease patient management. Learn to solve your most challenging antibiotic treatment decisions in this lecture series with MeMed co-founder and CEO Dr. Eran Eden. He will walk you through the challenges of distinguishing between bacterial and viral infections, despite advances in multiplex PCR pathogen panels. You will also learn about novel host-response technologies, which leverage the body's immune system and machine learning, and how they can be used to develop an actionable plan to achieve your antibiotic stewardship goals.

OUTCOMES

After attending this session, participants will be able to:

  • Have a better understanding about host-response technology
  • How MeMed BV and MeMed Key can aid your antibiotic stewardship program

MODERATOR

Eran Eden, PhD
Co-founder and CEO
MeMed

SPEAKER

Troy Boutelle
General Manager, MeMed USA
MeMed